Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use
University of Southern California · NCT07698470
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–55 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 45
- US sites recruiting
- 1
- Study start
- April 30, 2026
- Record last updated
- July 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Oral nicotine pouches (ONPs) are non-combustible nicotine products that may reduce cigarette craving and smoking cue-induced brain activity, supporting their potential as harm-reduction tools for adults who smoke cigarettes. This within-subject, repeated-measures study will evaluate the acute effects of a single 6 mg oral nicotine pouch on subjective craving and prefrontal neural responses to smoking-related cues using functional near-infrared spectroscopy (fNIRS). Participants will complete assessments before and after nicotine pouch administration following overnight nicotine abstinence to characterize changes in craving and neural cue reactivity.
Being studied: Oral Nicotine Pouch; Smoking Cue Reactivity Task
Conditions: Nicotine Dependence
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 21 years - 55 years
- Self-reported use of cigarettes within the past 30 days
- Biochemical confirmation of cigarette use:
o Carbon monoxide (CO) breath sample ≥10 ppm
- Fagerström Test for Nicotine Dependence (FTND) score ≥5, indicating moderate to high nicotine dependence
- Fluent in English
- Willing to try an oral nicotine pouch
- Willing to abstain from nicotine for at least 12 hours prior to each experimental session
Exclusion Criteria
- Age younger than 21 years or older than 55 years
- Biochemical evidence inconsistent with recent cigarette use:
o CO breath sample \<10 ppm
- Expressed intent to reduce or quit nicotine use within the next 30 days
- History of medical conditions contraindicated for nicotine use (e.g., uncontrolled hypertension, recent cardiac events)
- Primary use of non-cigarette products (e.g., cigars, pipe tobacco, smokeless tobacco)
- Prior use of oral nicotine products in their lifetime
Recruiting US locations
University of Southern California - 3641 Watt Way (HNB B22)
Los Angeles, CA 90089
Site contact: USC Nicotine and Tobacco Studies · 213-821-0807 · USCONPStudy@gmail.com
Study contacts (from the official record)
- USC Nicotine and Tobacco Studies · 213-821-0807 · USCONPStudy@gmail.com
Similar studies in California
All smoking & vaping studies in California →- RecruitingHealthy volunteersPhase 1
Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
University of California, San Francisco
- Location
- San Francisco, CA
- Eligibility basics
- Ages 21–65
- RecruitingHealthy volunteersPhase 1
Age-dependent Effects of Smoked and Oral Delta-9-THC
University of California, Los Angeles
- Location
- Los Angeles, CA
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Axsome Therapeutics, Inc.
- Location
- Lemon Grove, CA + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience Education
California State University, Northridge
- Location
- Northridge, CA
- Eligibility basics
- Ages 18+